+44(0)1235 431390 | sales@oxfordbiosystems.com
News
News from Oxford BioSystems
Oxford BioSystems is pleased to announce our exclusive contract with Tecan UK to supply the IBL product range in the UK and Republic of Ireland.
This agreement is effective from July 2023 and we are looking forward to working with new and existing customers to introduce a variety of exciting products from IBL.
For more information, please see the attached letter. Information about the IBL products can also be found on the Tecan IBL website.
Please do not hesitate to contact us if you have any questions or would like to arrange a meeting with one of our Account Managers.
Chronic kidney disease (CKD) affects not only kidney function but also bone metabolism, creating a c...
Why is a rapid G6PD test of interest? Glucose-6-phosphate dehydrogenase (G6PD) is a housekeeping enz...
At Oxford BioSystems we’ve observed that biomedical research increasingly relies on analysing multi...
Following on from our interview with Dr Victoria Munro back in March on our commitment to reducing o...
Saliva has been used for many years as a biological fluid for the detection of different biomarkers ...
Children and adolescents living with type 1 diabetes (T1D) frequently experience challenges related ...